Astrid E. Slagter

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Astrid E. Slagter, Edwin P. M. Jansen, Hanneke W.M. van Laarhoven et al. · BMC Cancer · 2018 · 147 citations · Full text

Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial

Astrid E. Slagter, B. Tudela, Romy M. van Amelsfoort et al. · European Journal of Cancer · 2020 · 24 citations · Full text

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial

Astrid E. Slagter, Marieke A. Vollebergh, Irene A. Caspers et al. · Gastric Cancer · 2021 · 23 citations · Full text

Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery

Astrid E. Slagter, Bipasha Chakrabarty, Ángela Lamarca et al. · Surgical Oncology · 2016 · 15 citations · Full text

Prognostic Factors, Neuroendocrine Tumours, Disease Relapse +11

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial

Irene A. Caspers, Karolina Sikorska, Astrid E. Slagter et al. · Cancers · 2021 · 13 citations · Full text